Leber's hereditary optic neuropathy (LHON) is a maternally-inherited form of acute, severe visual loss that affects otherwise healthy young people. LHON is the first human disease conclusively linked to an inherited mutation in mitochondrial DNA (mtDNA). The pathogenesis of visual loss in LHON appears to involve a complex interplay of genetic factors (primary and secondary mtDNA mutations) and epigenetic factors (most notably tobacco and alcohol use) that selectively affect the optic nerve. We hypothesize that the central pathogenetic feature of LHON is the net overall impairment of oxidative phosphorylation, which is induced by primary mtDNA mutations acting in concert with secondary mtDNA mutations and environmental factors. Genetic factors may predominate in some forms of acute optic neuropathy, while in others the epigenetic risk factor exposure is more prominent. The diversity of genetic factors (mtDNA mutations that occur in genes that are subunits of different complexes of oxidative phosphorylation) and epigenetic factors that can adversely affect oxidative phosphorylation may be reflected in distinctive phenotypic effects. To test these hypotheses, we propose studies with the following specific aims: 1. To define the pathogenetic role of secondary mtDNA mutations by determining their prevalence in groups of LHON probands that harbor each known primary mtDNA mutation and by using them to predict the coexistence of new primary mtDNA mutations in LHON probands. 2. To compare the mtDNA mutations associated with LHON to those associated with tobacco-alcohol amblyopia. Pathogenetic mtDNA mutations should occur in mtDNA-encoded subunits of all complexes of oxidative phosphorylation. MtDNA mutations might act as genetic susceptibility factors in tobacco-alcohol amblyopia and these patients should have an increased prevalence of known primary and secondary mtDNA mutations. A subset of patients with tobacco-alcohol amblyopia may represent a form fruste of LHON, while another subset may harbor unique mtDNA mutations. 3. To compare and contrast the genotype-specific clinical phenotypes associated with each primary mtDNA mutation to determine if the clinical phenotypes reflect the underlying molecular and biochemical heterogeneity. Conversely the specific features of the clinical phenotype may be predictive of the underlying mtDNA genotype. LHON may serve as a paradigm for mtDNA-mediated human diseases and for other diseases in which genetic and epigenetic factors pathogenetically interact.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY010864-04
Application #
2608663
Study Section
Visual Sciences C Study Section (VISC)
Project Start
1994-12-01
Project End
1999-11-30
Budget Start
1997-12-01
Budget End
1999-11-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Simon, D K; Tarnopolsky, M A; Greenamyre, J T et al. (2001) A frameshift mitochondrial complex I gene mutation in a patient with dystonia and cataracts: is the mutation pathogenic? J Med Genet 38:58-61
Tsao, K; Aitken, P A; Johns, D R (1999) Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy. Br J Ophthalmol 83:577-81
Simon, D K; Pulst, S M; Sutton, J P et al. (1999) Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 53:1787-93
Austin, S A; Vriesendorp, F J; Thandroyen, F T et al. (1998) Expanding the phenotype of the 8344 transfer RNAlysine mitochondrial DNA mutation. Neurology 51:1447-50
Engle, E C; Goumnerov, B C; McKeown, C A et al. (1997) Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. Ann Neurol 41:314-25
Fadic, R; Russell, J A; Vedanarayanan, V V et al. (1997) Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 49:239-45
Johns, D R (1996) The other human genome: mitochondrial DNA and disease. Nat Med 2:1065-8
Hofhaus, G; Johns, D R; Hurko, O et al. (1996) Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy. J Biol Chem 271:13155-61
Johns, D R; Newman, N J (1995) Hereditary optic neuropathies. Semin Ophthalmol 10:203-13
Johns, D R (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. N Engl J Med 333:638-44